Works matching IS 17762596 AND DT 2017 AND VI 12 AND IP 5
Results: 12
Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Is 1,25-Dihydroxyvitamin D3 Receptor Expression a Potential Achilles' Heel of CD44+ Oral Squamous Cell Carcinoma Cells?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article